- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Chemed Corp (CHE)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/03/2025: CHE (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $574.25
1 Year Target Price $574.25
| 2 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.66% | Avg. Invested days 49 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 6.18B USD | Price to earnings Ratio 22.44 | 1Y Target Price 574.25 |
Price to earnings Ratio 22.44 | 1Y Target Price 574.25 | ||
Volume (30-day avg) 3 | Beta 0.47 | 52 Weeks Range 407.30 - 621.35 | Updated Date 12/4/2025 |
52 Weeks Range 407.30 - 621.35 | Updated Date 12/4/2025 | ||
Dividends yield (FY) 0.49% | Basic EPS (TTM) 18.91 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.02% | Operating Margin (TTM) 11.96% |
Management Effectiveness
Return on Assets (TTM) 12.97% | Return on Equity (TTM) 24.11% |
Valuation
Trailing PE 22.44 | Forward PE 17.04 | Enterprise Value 6090265849 | Price to Sales(TTM) 2.44 |
Enterprise Value 6090265849 | Price to Sales(TTM) 2.44 | ||
Enterprise Value to Revenue 2.41 | Enterprise Value to EBITDA 13.95 | Shares Outstanding 14108915 | Shares Floating 13876823 |
Shares Outstanding 14108915 | Shares Floating 13876823 | ||
Percent Insiders 2.01 | Percent Institutions 101.6 |
Upturn AI SWOT
Chemed Corp

Company Overview
History and Background
Chemed Corporation was founded in 1971. Initially a chemical distributor, it transitioned to healthcare in the 1990s with the acquisition of VITAS Healthcare. It continued to expand its healthcare services with other acquisitions, ultimately divesting its non-healthcare operations.
Core Business Areas
- VITAS Healthcare: VITAS Healthcare provides hospice care services to patients with life-limiting illnesses.
- Roto-Rooter: Roto-Rooter provides plumbing, drain cleaning, and water restoration services to residential and commercial customers.
Leadership and Structure
Chemed is led by CEO Kevin McNamara. The organizational structure includes separate management teams for VITAS and Roto-Rooter, reporting to the corporate leadership.
Top Products and Market Share
Key Offerings
- Hospice Care (VITAS): VITAS Healthcare provides end-of-life care services. While exact market share fluctuates, VITAS is one of the largest hospice providers in the US. Competitors include LHC Group, Amedisys, and AccentCare.
- Plumbing and Drain Cleaning (Roto-Rooter): Roto-Rooter offers plumbing, drain cleaning, and water restoration. Roto-Rooter is a well-established brand with a significant market presence. Competitors include ServiceMaster (Terminix), Neighborly brands, and smaller local plumbing companies.
Market Dynamics
Industry Overview
The hospice care industry is growing due to the aging population and increasing acceptance of end-of-life care options. The plumbing and drain cleaning industry is relatively stable, driven by ongoing maintenance needs and emergency repairs.
Positioning
Chemed holds a leading position in the hospice care market through VITAS Healthcare. Roto-Rooter is a well-recognized brand in the plumbing and drain cleaning industry, providing a stable and predictable revenue stream.
Total Addressable Market (TAM)
The TAM for hospice care is estimated in the tens of billions of dollars annually, driven by the aging population and Medicare reimbursements. The plumbing services TAM is also significant, driven by both residential and commercial needs. Chemed is well-positioned within its respective TAMs due to brand recognition and market share.
Upturn SWOT Analysis
Strengths
- Established Brand Names (VITAS, Roto-Rooter)
- Leading Market Position in Hospice Care
- Stable Revenue Stream from Plumbing Services
- Experienced Management Team
- Strong Cash Flow Generation
Weaknesses
- Dependence on Government Reimbursements (Hospice)
- Exposure to Economic Downturns (Plumbing)
- Competition in Both Hospice and Plumbing Industries
- Potential Regulatory Scrutiny (Hospice)
- Labor Shortages
Opportunities
- Expanding Hospice Services to New Geographic Areas
- Increasing Market Share in Plumbing Services
- Acquiring Smaller Hospice or Plumbing Companies
- Developing New Technologies for Plumbing Services
- Partnerships with Healthcare Providers
Threats
- Changes in Government Reimbursement Policies
- Increased Competition in Hospice and Plumbing
- Economic Recession Impacting Plumbing Demand
- Rising Labor Costs
- Cybersecurity Threats
Competitors and Market Share
Key Competitors
- LHCG
- AMED
- SVCS
Competitive Landscape
Chemed's VITAS Healthcare competes with other large hospice providers. Its advantage lies in its scale and established reputation. Roto-Rooter faces competition from national and local plumbing companies. Roto-Rooter's advantage is its brand recognition and national presence.
Growth Trajectory and Initiatives
Historical Growth: Chemed's growth has been driven by acquisitions and organic growth in both its hospice and plumbing businesses.
Future Projections: Analyst estimates project continued growth in revenue and earnings, driven by the aging population and demand for hospice services, as well as the relatively stable demand for plumbing services.
Recent Initiatives: Recent initiatives can include strategic acquisitions and partnerships to expand its reach in the hospice and plumbing industries.
Summary
Chemed is a company with a leading market position in hospice care and a stable plumbing business. VITAS Healthcare is a key revenue driver with growing opportunities, but is vulnerable to changes in healthcare regulations. Roto-Rooter provides a stable and predictable revenue stream. Chemed needs to watch out for rising labor costs and competition in both industries.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Industry Reports
- Analyst Reports
- Company Website
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly. Conduct your own due diligence before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Chemed Corp
Exchange NYSE | Headquaters Cincinnati, OH, United States | ||
IPO Launch date 1973-05-03 | CEO, President & Director Mr. Kevin J. McNamara | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 15695 | Website https://www.chemed.com |
Full time employees 15695 | Website https://www.chemed.com | ||
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

